Literature DB >> 16028218

Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia.

Sabrina Tosi1, Erica Ballabio, Andrea Teigler-Schlegel, Jackie Boultwood, Jochen Bruch, Jochen Harbott.   

Abstract

Chromosome abnormalities of 6q are not frequently observed in myeloid disorders. In this article, we report the incidence of these chromosome changes in childhood myeloid leukemia as 2%-4% based on the cytogenetic database of a single institution. We applied fluorescence in situ hybridization (FISH) to characterize precisely the types of 6q abnormalities in seven patients (six with acute myeloid leukemia and one with myelodysplastic syndrome). They carried various translocations involving different breakpoints in 6q, as confirmed by FISH using a whole-chromosome-6 paint. Four cases were reported as t(6;11), although the breakpoints varied. Among these, we identified a novel translocation, t(6;11)(q24.1;p15.5), in a patient with acute megakaryoblastic leukemia. Molecular cytogenetic studies using the PAC clone RP5-1173K1 localized the genomic breakpoint on chromosome 11 to within the NUP98 gene. The breakpoint on chromosome 6 was narrowed down to a 500-kb region between BAC clones RP11-721P14 and RP11-39H10. Reverse-transcription PCR was performed using a forward primer specific for NUP98 and a reverse primer for the candidate gene in the 500-kb interval in 6q. This experiment resulted in the identification of a new fusion between NUP98 and C6orf80. Further studies will aim to fully characterize C6orf80 and will elucidate the role of this new NUP98 fusion in myeloid leukemia. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16028218     DOI: 10.1002/gcc.20233

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.

Authors:  Nayan J Sarma; Nabeel R Yaseen
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 2.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

3.  Functional analysis of the NUP98-CCDC28A fusion protein.

Authors:  Arnaud Petit; Christine Ragu; Gwendoline Soler; Chris Ottolenghi; Caroline Schluth; Isabelle Radford-Weiss; Sylvie Schneider-Maunoury; Isabelle Callebaut; Nicole Dastugue; Harry A Drabkin; Olivier A Bernard; Serge Romana; Virginie Penard-Lacronique
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

4.  Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression.

Authors:  Jennifer Rhodes; Adam Amsterdam; Takaomi Sanda; Lisa A Moreau; Keith McKenna; Stefan Heinrichs; Neil J Ganem; Karen W Ho; Donna S Neuberg; Adam Johnston; Yebin Ahn; Jeffery L Kutok; Robert Hromas; Justin Wray; Charles Lee; Carly Murphy; Ina Radtke; James R Downing; Mark D Fleming; Laura E MacConaill; James F Amatruda; Alejandro Gutierrez; Ilene Galinsky; Richard M Stone; Eric A Ross; David S Pellman; John P Kanki; A Thomas Look
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

Review 5.  Nuclear pore proteins and cancer.

Authors:  Songli Xu; Maureen A Powers
Journal:  Semin Cell Dev Biol       Date:  2009-03-18       Impact factor: 7.727

Review 6.  Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Authors:  Nicole L Michmerhuizen; Jeffery M Klco; Charles G Mullighan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

7.  Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias.

Authors:  Shahzya Chaudhury; Caitríona O'Connor; Ana Cañete; Joana Bittencourt-Silvestre; Evgenia Sarrou; Áine Prendergast; Jarny Choi; Pamela Johnston; Christine A Wells; Brenda Gibson; Karen Keeshan
Journal:  Nat Commun       Date:  2018-12-11       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.